News | January 22, 2024
AstraZeneca Pharma India receives permission to import new drug
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
Demonstrate significant bleed reduction in hemophilia A and B
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Subscribe To Our Newsletter & Stay Updated
